Coupling component for transmitting medical substances

Information

  • Patent Grant
  • 9039672
  • Patent Number
    9,039,672
  • Date Filed
    Friday, August 23, 2013
    11 years ago
  • Date Issued
    Tuesday, May 26, 2015
    9 years ago
Abstract
A coupling component is disclosed for transmitting medical substances, comprising two channels for conveyance of medical substances in two substantially opposite directions and a means for releasable connection to a second coupling component having a further channel for creating a coupling. The connecting means is a thread. A method for conveying medical substances to and from a container is also disclosed.
Description
FIELD OF THE INVENTION AND PRIOR ART

The present invention relates to a coupling component for transmitting medical substances, comprising two channels for conveyance of medical substances in two substantially opposite directions and a means for releasable connection to a second coupling component having a further channel, for creating a coupling. Furthermore, the invention relates to a coupling for transmitting medical substances, comprising a first component having two channels for conveyance of medical substances in two substantially opposite directions, a second component having a further channel and a means for releasable connection of the first and the second component to each other for creating the coupling. The invention also relates to a method for conveyance of medical substances to and from a container, in which method a coupling component having two channels for conveyance of medical substances in two substantially opposite directions be connected to a second coupling component of a container, which second coupling component has a further channel.


The invention may be applied in different situations when medical substances are to be handled, but hereinafter the particular, but not in any way limiting for the invention, fields of application constituting a means for administration of fluids to/from infusion bags, which is desired in medical treatment for instance, will be described for illuminating purposes.


Infusion bags are used for intravenous delivery of fluids and medically effective substances to human beings and animals. For this reason, the infusion bag is provided with an outlet through which fluid may flow to a component connected to the patient, such as a cannula or the like, and further into the body of the patient. When preparing the fluids which are to be administrated to the body from the infusion bag, a usual method is that medically effective substances are supplied to a pre-sealed infusion bag which is filled with a transport fluid, such as a sodium chloride solution or a glucose solution. The preparation is performed by injecting the medically effective substance via an inlet into the bag.


For accomplishing the desired transportations of fluid a combined inlet and outlet of the infusion bag together with a coupling device which is denoted “spike” are often used. The spike has a first pointed end by means of which a membrane arranged in a narrow passage of the infusion bag, constituting inlet/outlet of the infusion bag, may be penetrated so that the infusion bag be opened towards two channels arranged in the spike when the spike is introduced in the inlet/outlet of the infusion bag. One of the channels is intended for conveyance of fluid in a direction from the infusion bag towards the patient and the other channel is intended for injection of medical substances into the infusion bag. In the other end of the spike are members arranged at the mouths of the channels for connection to other components, such as flexible tubes for conveyance of the fluid further to the patient and cannulas for the injection of medical substances to the infusion bag.


However, it has appeared that during certain extreme conditions there is a risk that the spike, which by insertion in the above mentioned narrow passage of the infusion bag is relatively loosely interconnected to the infusion bag, may unintentionally come loose from the infusion bag if the equipment is handled carelessly or by carelessness in connection with other treatment of the patient. The system of spike and infusion bag is depended of the friction between the infusion bag and the spike to prevent the spike from coming loose from the infusion bag. Furthermore, the spike has the disadvantage that leakage from the infusion bag to the environment may occur when the spike is introduced and the membrane is penetrated. In some cases the fluids which are to be administrated to the patient may be harmful to other persons than the patient who has been prescribed the treatment as a result of an indication of a specific decease. This is particularly the case when repeated long-term exposure is concerned, which can happened to medical staff when preparing and connecting infusion bags every day if the requisite security regulations are not fulfilled. A further disadvantage with the use of a spike which during the connection penetrates a membrane of the infusion bag for providing the fluid administration channels is that the connection step itself cannot be made in advance to later on enable conveyance of fluid from the infusion bag to a receiving unit connected to the spike, but the channels have to be opened instantaneously at the connecting moment.


THE OBJECT OF THE INVENTION AND SUMMARY OF THE INVENTION

One object of the invention is to provide a coupling component/coupling of the kind defined by way of introduction for transmitting medical substances, in which coupling component/coupling at least some of the discussed disadvantages of such previously known coupling devices has been reduced to a great extent.


This object is achieved by providing a coupling component. By a coupling component/coupling having the feature that the connecting means is a thread/a thread joint it is ensured that the coupling not be unintentionally uncoupled when the coupling is tension loaded. By means of the thread/thread joint a coupling safe against tension load may be obtained at the same time as the connection may be accomplished quickly and safely in one simple operation. This implies that in the use of a device according to the invention, when an infusion bag is connected to a patient, an increased safety to the patient may be achieved at the same time as it is possible to deliver medical substances to the infusion bag and intravenously administrate fluid to the patient from the infusion bag. Furthermore the invention enables the use of other means, such as breakable fluid barrier plugs, for opening the infusion bag towards the channels and there is possible to ensure that leakage to the environment is prevented by tightening the thread joint before the infusion bag be opened towards the channels.


A further object of the invention is to provide a method of the kind defined by way of introduction, in which method a container and a coupling component, having two channels for conveyance of medical substances in two substantially opposite directions, may be connected to each other for conveyance of medical substances via the channels without the container being instantaneously opened towards the two channels.


This object is achieved by providing a method as described herein. Hereby the connection may be accomplished so as to later on enable conveyance of a medical substance from the container via one first of said two channels and/or conveyance of a medical substance to the container via the other of said two channels.


The invention also relates to an infusion bag and an infusion arrangement.





SHORT DESCRIPTION OF THE DRAWINGS

A description in greater detail of exemplifying embodiments of the invention will follow below with reference to the attached drawings.


In the drawings:



FIG. 1 is a sectional view of an infusion bag and a spike according to prior art connected to the infusion bag,



FIG. 2 is a sectional view of an infusion bag and a coupling according to the invention for transmitting medical substances, and



FIG. 3 is a sectional view illustrating a variant of the coupling according to invention in FIG. 2.





DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION

In FIG. 1 an infusion bag 1 and a coupling device 2 of the type called spike according to prior art are illustrated. The coupling device 2 is provided with a pointed part 3 which is introducible in a part 4 which constitutes an inlet/outlet of the infusion bag 1. This part 4 of the infusion bag 1 is designed as a flexible tube with a circular cross-section corresponding to the cross-section of the pointed part 3 of the spike and has, before the introduction of the pointed part of the spike, a sealing membrane arranged at the mouth 5 thereof. In the introduction of the spike the pointed part 3 penetrates the membrane and the infusion bag 1 be opened towards two channels 6, 7 arranged in the spike. Thereafter, medical substances may be injected into the infusion bag 1 via one first 6 of the channels and fluid may be transported out from the bag via the other 7 of the channels to a receiving unit (not illustrated).


In FIG. 2 an infusion bag 10, a receiving unit 11 connected to the infusion bag and a coupling 12 according to the invention are illustrated. The coupling 12 comprises a first component 13, a second component 14 and a means 15 for releasable connection of the first 13 and second 14 components to each other for creating the coupling 12. The first component 13 comprises a male fitting 16 provided with two channels 17, 18 for conveyance of medical substances in two substantially opposite directions. One first channel 17 for injecting medical substances into the infusion bag 10 and one second channel 18 for conveyance of fluid out of the infusion bag 10 to the receiving unit 11, which may be for example a chamber or the like for intravenous treatment. The second component 14 is provided with a further channel 19 intended to be in communication with said two channels 17, 18 of the first component 13.


The connecting means 15 is a thread joint having the characteristic that said first 13 and second 14 components are locked against rectilinear movement relative to each other when being connected to each other and the coupling 12 is tension loaded. The first component 13 has a ring 20 partly enclosing the male fitting 16, which ring has a internal thread 21 constituting part of the thread joint. The ring 20 is concentrically arranged relative to the male fitting 16. The second component 14 comprises a female fitting 22 provided with said further channel 19 and an external thread 23 corresponding to said thread 21 of the ring 20 and constituting part of the thread joint. When the first and second components are to be connected to each other, i.e. when the first and the second components be screwed together, the male fitting 16 be introduced into the female fitting 22 to form a connection between said two channels 17, 18 of the first component 13 and the further channel 19 of the second component 14, which connection is sealed relative to the environment. For this purpose the male fitting 16 and/or female fitting 22 may be designed with a certain taper so that when the male fitting and the female fitting have been brought together a certain distance the outer surface 24 of the male fitting will abut against the inner surface 25 of the female fitting, and then further movement of the components in the introduction direction relative to each other is not longer possible and a sealing between the male fitting 16 and the female fitting 22 is obtained when tightening the thread joint 15.


Although the coupling component according to the invention, i.e. said first component, which has the both channels, is designed as a male fitting of the coupling in the illustrated example, in another embodiment it could be designed as a female fitting 22a of the coupling 12, such as illustrated in FIG. 3, and the other component, which is arranged on for example an infusion bag, would in such a case be designed as a corresponding male fitting 16a. Of course it is also possible to change places of the threads in comparison to the illustrated embodiment in FIG. 2, so that instead, the second component including the female fitting is provided with an internal thread and the first component including the male fitting is provided with an external thread. The threads may for example be arranged on rings such as described above.


Advantageously the design of the threads 21, 23, the male fitting 16 and the female fitting 22 may be in accordance with a so called luer fitting coupling such as in the illustrated embodiments.


The coupling component 13 according to the invention is provided with a port 26 for injection of a medical substance to the first of the channels 17 and further conveyance of this substance to the infusion bag 10. For this purpose, the first channel 17 has also an outlet 27 arranged at one end of the first coupling component 13 which exhibits the connecting means 15 and the second coupling component 14 has said further channel 19, which communicates with the first 17 and the second 18 channels, for introduction or removal of liquid to/from the infusion bag 10.


Within the frame of the invention the injection port 26 may be designed in different ways depending on which injection component is to be connected. In the illustrated embodiment the injection port 26 has a first flexible membrane 28 for co-operation with a second flexible membrane (not illustrated) arranged in an injection component 29 which is connectable to the injection port 26. The first membrane 28 is suitably air- and liquid proof and penetratable by an injection needle. To achieve a sealed connection of such a injection component 29 to the injection port 26, the injection port has a means 30 for holding said second flexible membrane with a pressure against said first flexible membrane 28. This holding means 30 may for example be constituted by a snap lock device, bayonet coupling or similar. The current pressure in question may suitably be chosen so that said first and second membranes are pressed together to a pressure exceeding the yield point of the both membranes, which implies that fluid cannot be pressed out through the contact surfaces of the membranes and a sealed connection is obtained.


If a pressure exceeding the yield point is applied the membranes will exhibit same properties at the compressed surfaces as in an arbitrary cross-section through the membranes, which implies that liquid cannot be pressed through the contact surfaces of the membranes. Such a characteristic may be obtained when the said first and second membranes has been pressed together to a pressure exceeding 150 kPa. Since the device risks to be destroyed if it is subjected to exceedingly large contact forces, the contact pressure should be restricted as much as possible. It has been proved in experiments that the sufficient sealing without any risk of failure is obtained with contact forces of up to 11, 1N, which corresponds to 656 kPA. Preferably, the contact pressure is within the interval 300-473 kPa.


At one end of the first coupling component 13, which end exhibits the connecting means 15 for establishing communication with the further channel 19 of the second coupling component 14 of the infusion bag 10, the second channel 18 has a inlet 31. Furthermore, the first coupling component 13 has in the other end thereof a port 32 which works as an outlet for the second channel 18. Within the frame of the invention the outlet port 32 may be designed in several different ways depending on which unit is to be connected to the outlet port. For example a snap coupling 33 may be used in combination with a friction joint for retaining a connection unit at the outlet port. In accordance with an variant thereof the entire coupling component 13, or at least the part 13a closest to the outlet port 32a of the coupling component 13, may be made of a first material and the connection unit 34 corresponding to the outlet port may be made of a second material. In this connection, materials having considerably different elasticity may be chosen, preferably so that the second material has a considerable higher elasticity than the first material for providing sufficient sealing action between the coupling component 13 and the connection unit 34 and at the same time achieve that the coupling component 13 having a lower elasticity has a high resistance against deformation.


In the extension of the further channel 19, i.e. in a combined inlet and outlet 35 of the infusion bag 10 a breakable fluid barrier plug 36 is arranged. In a state of not has been broken the fluid barrier plug 36 prevents in-flowing and out-flowing via the combined inlet and outlet 35 of the infusion bag 10 which implies that the infusion bag 10 is sealed. After connecting the infusion bag 10 to the coupling component 13 according to the invention, and eventually to other components, the fluid barrier plug 36 may be broken so that the combined inlet and outlet 35 of the infusion bag 10 be opened towards the both channels 17, 18 in the coupling component 13 according to the invention.


The method according to the invention comprises connecting of a coupling component 13 having two channels 17, 18 for conveyance of medical substances in two substantially opposite directions to a second coupling component 14 of a container 10, such as a infusion bag 10, which second coupling component has a further channel 19. After the coupling component 13 and the container 10 have been connected to each other, the container 10 be opened by means of a member 36, preferably in the form of a breakable fluid barrier plug or similar, which member is suitably arranged in a combine inlet and outlet 35 of the container 10, towards the both channels 17, 18 for enabling transportation of a medical substance to the container 10 via one first 17 of said two channels, and for enabling transportation of a medical substances from the container 10.


Preferably, the first 13 and the second 14 coupling components are connected to each other by a thread joint 15. By means of the thread joint 15 a male fitting 16 of the first component 13 may be brought into contact with a corresponding female fitting 22 of the second component 14 to form a connection sealed relative to the environment between said two channels 17, 18 and the further channel 19 of the second coupling component 14.


Then, the container 10 be opened towards 17, 18 by breaking the breakable fluid barrier plug 36. Thereafter, a medical substance may be injected to the container via one first 17 of said channels. Advantageously, the medical substance is injected by means of a component via a port arranged in the first coupling component which port has a first flexible membrane for co-operation with a second flexible membrane arranged in the injection component. Preferably, said second flexible membrane is held against said first flexible membrane with a pressure during the injection to prevent leakage and wastage during the injection. It has been proved that by holding said second flexible membrane against said first flexible membrane with a pressure exceeding the yield point of the first and second membranes it is ensured that the membranes fit tightly to each other in such away that fluid transportation between these membranes is prevented and thereby leakage to the environment is avoided. Parallel with the injection, the liquid state medical substance in the container may be transported via the second 18 of said two channels to a receiving unit.


It is stressed that the invention is not restricted to the exemplifying embodiments; rather within the scope of protection defined by the following claims, the invention may be varied in several ways once the idea of the invention is disclosed.

Claims
  • 1. A method for conveyance of medical fluids to an infusion bag, comprising the steps of: connecting a first coupling component having two channels for conveyance of medical fluids in two opposite directions to a second coupling component of the infusion bag, wherein said first coupling component is provided with an opening for injection of a medical substance to a first of said two channels, wherein said opening is closed with a first piercable flexible membrane for abutting cooperation with a second flexible membrane of an injection component that is connectable to said opening, said second coupling component having a third channel with a lumen, said third channel is provided with a breakable fluid barrier that is arranged to remain intact during connection and upon complete engagement of the first coupling component to the second coupling component, wherein the breakable fluid barrier is contained within the lumen of the third channel; connecting the first coupling component and the second coupling component of the infusion bag allowing said second flexible membrane to be held against said first flexible membrane with a pressure exceeding the yield point of the first membrane and second membrane, and opening the infusion bag towards said two channels after the first coupling component and the infusion bag have been connected to each other, for enabling conveyance of a medical fluid into the infusion bag via one first of said two channels.
  • 2. A method according to claim 1, whereby opening the infusion bag towards said two channels comprises breaking the breakable fluid barrier plug.
  • 3. A method according to claim 1, further comprising opening the infusion bag towards said two channels by a member arranged in the infusion bag.
  • 4. A method according to claim 1, further comprising injecting a medical fluid to the infusion bag via a first of said two channels.
  • 5. A method according to claim 4, further comprising injecting the medical fluid via the opening arranged in the first coupling component.
  • 6. A method according to claim 1, further comprising holding said second flexible membrane against said first flexible membrane with a pressure exceeding 150 kPa.
Priority Claims (1)
Number Date Country Kind
0202174 Jul 2002 SE national
CROSS-REFERENCE TO RELATED APPLICATIONS

This Application is a divisional of U.S. patent application Ser. No. 11/030,098 filed Jan. 7, 2005, now allowed, which is a 371 of Application No. PCT/SE2003/001193 filed Jul. 8, 2003 which claims priority from U.S. Provisional Application No. 60/394,288 filed Jul. 9, 2002 and Swedish Patent Application number 0202174-9, filed Jul. 9, 2002, the disclosures of which are hereby incorporated by reference in their entirety.

US Referenced Citations (166)
Number Name Date Kind
1844342 Berman Feb 1932 A
2010417 Schwab Aug 1935 A
2697438 Hickey Dec 1954 A
2717599 Huber Sep 1955 A
3064651 Henderson Nov 1962 A
3071135 Baldwin et al. Jan 1963 A
3308822 De Luca Mar 1967 A
3390677 Razimbaud Jul 1968 A
3448740 Figge Jun 1969 A
3788320 Dye Jan 1974 A
3822700 Pennington Jul 1974 A
3976073 Quick et al. Aug 1976 A
3986508 Barrington Oct 1976 A
4161178 Genese Jul 1979 A
4340049 Munsch Jul 1982 A
4479989 Mahal Oct 1984 A
4490139 Huizenga et al. Dec 1984 A
4516967 Kopfer May 1985 A
4564054 Gustavsson Jan 1986 A
4573967 Hargrove et al. Mar 1986 A
4576211 Valentini et al. Mar 1986 A
4581016 Gettig Apr 1986 A
4588403 Weiss et al. May 1986 A
4600040 Naslund Jul 1986 A
4629455 Kanno Dec 1986 A
4632673 Tiitola et al. Dec 1986 A
4657541 Ichikawa et al. Apr 1987 A
4673404 Gustavsson Jun 1987 A
4737150 Baeumle et al. Apr 1988 A
4752287 Kurtz et al. Jun 1988 A
4768568 Fournier et al. Sep 1988 A
4792329 Schreuder Dec 1988 A
4822340 Kamstra Apr 1989 A
4826492 Magasi May 1989 A
4826500 Rautsola May 1989 A
4834717 Haber et al. May 1989 A
4842585 Witt Jun 1989 A
4850978 Dudar et al. Jul 1989 A
4864717 Baus, Jr. Sep 1989 A
4872494 Coccia Oct 1989 A
4878897 Katzin Nov 1989 A
4889529 Haindl Dec 1989 A
4898209 Zbed Feb 1990 A
4932937 Gustavsson et al. Jun 1990 A
4944736 Holtz Jul 1990 A
4964855 Todd et al. Oct 1990 A
4982769 Fournier et al. Jan 1991 A
4997083 Loretti et al. Mar 1991 A
5017186 Arnold May 1991 A
5041105 D'Alo et al. Aug 1991 A
5061264 Scarrow Oct 1991 A
5071413 Utterberg Dec 1991 A
5122116 Kriesel et al. Jun 1992 A
5122123 Vaillancourt Jun 1992 A
5137524 Lynn et al. Aug 1992 A
5158554 Jepson et al. Oct 1992 A
5176673 Marrucchi Jan 1993 A
5188629 Shimoda Feb 1993 A
5199947 Lopez et al. Apr 1993 A
5201725 Kling Apr 1993 A
5207658 Rosen et al. May 1993 A
5232109 Tirrell et al. Aug 1993 A
5254097 Schock et al. Oct 1993 A
5279576 Loo et al. Jan 1994 A
5279583 Shober, Jr. et al. Jan 1994 A
5279605 Karrasch et al. Jan 1994 A
5312366 Vailancourt May 1994 A
5328480 Melker et al. Jul 1994 A
5334163 Sinnett Aug 1994 A
5334180 Adolf et al. Aug 1994 A
5356406 Schraga Oct 1994 A
5385545 Kriesel et al. Jan 1995 A
5385547 Wong et al. Jan 1995 A
5389085 D'Alessio et al. Feb 1995 A
5405326 Haber et al. Apr 1995 A
5447501 Karlsson et al. Sep 1995 A
5456675 Wolbring et al. Oct 1995 A
5470522 Thome et al. Nov 1995 A
5478328 Silverman et al. Dec 1995 A
5478337 Okamoto et al. Dec 1995 A
5492531 Post et al. Feb 1996 A
5514117 Lynn May 1996 A
5515871 Bittner et al. May 1996 A
5536259 Utterberg Jul 1996 A
5575780 Saito Nov 1996 A
5593028 Haber et al. Jan 1997 A
5613954 Nelson et al. Mar 1997 A
5632735 Wyatt et al. May 1997 A
5647845 Haber et al. Jul 1997 A
5685866 Lopez Nov 1997 A
5735841 Bourguignon et al. Apr 1998 A
5752942 Doyle et al. May 1998 A
5755712 Szempruch et al. May 1998 A
5766147 Sancoff et al. Jun 1998 A
5766211 Wood et al. Jun 1998 A
5782872 Muller Jul 1998 A
5795336 Romano et al. Aug 1998 A
5817083 Shemesh et al. Oct 1998 A
5820609 Saito Oct 1998 A
5837262 Golubev et al. Nov 1998 A
5879345 Aneas Mar 1999 A
5897526 Vaillancourt Apr 1999 A
5984899 D'Alessio et al. Nov 1999 A
6063068 Fowles et al. May 2000 A
6070623 Aneas Jun 2000 A
6071270 Fowles et al. Jun 2000 A
6090091 Fowles et al. Jul 2000 A
6113068 Ryan Sep 2000 A
6113583 Fowles et al. Sep 2000 A
6142446 Leinsing Nov 2000 A
6146362 Turnbull et al. Nov 2000 A
6209738 Jansen et al. Apr 2001 B1
6221065 Davis Apr 2001 B1
6253804 Safabash Jul 2001 B1
6258078 Thilly Jul 2001 B1
6364143 Knierbein Apr 2002 B1
6387074 Horppu et al. May 2002 B1
6453956 Safabash Sep 2002 B2
6471674 Emig et al. Oct 2002 B1
6517523 Kaneko et al. Feb 2003 B1
6537263 Aneas Mar 2003 B1
6571837 Jansen et al. Jun 2003 B2
6591876 Safabash Jul 2003 B2
6644367 Savage et al. Nov 2003 B1
6685692 Fathallah Feb 2004 B2
6709424 Knierbein Mar 2004 B1
6715520 Andreasson et al. Apr 2004 B2
6726672 Hanly et al. Apr 2004 B1
6786244 Jones Sep 2004 B1
6960194 Hommann et al. Nov 2005 B2
7080672 Fournie et al. Jul 2006 B2
7297140 Orlu et al. Nov 2007 B2
7703486 Costanzo Apr 2010 B2
7744581 Wallen et al. Jun 2010 B2
8491563 Wallen Jul 2013 B2
20010047154 Jepson et al. Nov 2001 A1
20020082586 Finley et al. Jun 2002 A1
20020177819 Barker et al. Nov 2002 A1
20030070726 Andreasson et al. Apr 2003 A1
20030106610 Roos et al. Jun 2003 A1
20030107628 Fowles et al. Jun 2003 A1
20030177819 Maale Sep 2003 A1
20030199846 Fowles et al. Oct 2003 A1
20030233083 Houwaert et al. Dec 2003 A1
20040116858 Heinz et al. Jun 2004 A1
20040199139 Fowles et al. Oct 2004 A1
20040215147 Wessman et al. Oct 2004 A1
20050215977 Uschold Sep 2005 A1
20060025747 Sullivan et al. Feb 2006 A1
20060106360 Wong May 2006 A1
20060111667 Matsuura et al. May 2006 A1
20060157984 Rome et al. Jul 2006 A1
20060186045 Jensen et al. Aug 2006 A1
20070021725 Villette Jan 2007 A1
20070060841 Henshaw Mar 2007 A1
20070106244 Mosler et al. May 2007 A1
20070179441 Chevallier Aug 2007 A1
20070270759 Pessin Nov 2007 A1
20080045919 Jakob et al. Feb 2008 A1
20080103453 Liversidge May 2008 A1
20080103485 Kruger May 2008 A1
20080172039 Raines Jul 2008 A1
20080223484 Horppu Sep 2008 A1
20080287920 Fangrow et al. Nov 2008 A1
20080312634 Helmerson et al. Dec 2008 A1
20090254042 Gratwohl et al. Oct 2009 A1
Foreign Referenced Citations (41)
Number Date Country
200112863 May 2001 AU
2005519 Oct 1979 DE
0255025 Feb 1988 EP
0259582 Mar 1988 EP
0285424 May 1988 EP
0311787 Apr 1989 EP
0376629 Jul 1990 EP
0803267 Oct 1997 EP
0819442 Jan 1998 EP
0995453 Apr 2000 EP
1060730 Dec 2000 EP
1484073 Dec 2004 EP
1731128 Dec 2006 EP
2757405 Jun 1998 FR
2780878 Jan 2000 FR
1579065 Nov 1980 GB
4912690 May 1972 JP
288664 Jul 1990 JP
3030963 Aug 1996 JP
2000167022 Jun 2000 JP
2001505092 Apr 2001 JP
2001293085 Oct 2001 JP
482670 Apr 2002 TW
WO-8404672 Dec 1984 WO
WO-8404673 Dec 1984 WO
WO-9003536 Apr 1990 WO
WO-9819724 May 1998 WO
WO-9927886 Jun 1999 WO
WO-9962578 Dec 1999 WO
WO-0005292 Feb 2000 WO
WO-0035517 Jun 2000 WO
WO-0180928 Nov 2001 WO
WO-0202048 Jan 2002 WO
WO-0211794 Feb 2002 WO
WO-02064077 Aug 2002 WO
WO-02076540 Oct 2002 WO
WO-2005074860 Aug 2005 WO
WO-2006082350 Aug 2006 WO
WO-2006083333 Aug 2006 WO
WO-2006138184 Dec 2006 WO
WO-2008115102 Sep 2008 WO
Non-Patent Literature Citations (5)
Entry
JP Appln No. 2003-583539, Office Action dated May 1, 2009, 3 pgs.
JP Office Action in Appln. 2003-577789, dated Feb. 24, 2009, 4 pgs.
PCT International Search Report in PCT/EP2008/067522, dated Aug. 12, 2009, 2 pgs.
PCT International Search Report in PCT/EP2008/067535, dated Oct. 13, 2009, 3 pgs.
Taiwan Search Report for Appln. 092106323, dated Mar. 21, 2003, 4 pgs.
Related Publications (1)
Number Date Country
20140000754 A1 Jan 2014 US
Divisions (1)
Number Date Country
Parent 11030098 Jan 2005 US
Child 13974380 US